Literature DB >> 10980883

Analysis of dual-chamber pacing as a treatment for refractory limiting symptoms in patients with obstructive hypertrophic cardiomyopathy.

B J Maron1.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10980883     DOI： 10.1007/s11886-000-0009-2

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  12 in total

1.  Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing In Cardiomyopathy.

Authors:  C Linde; F Gadler; L Kappenberger; L Rydén
Journal:  Am J Cardiol       Date:  1999-03-15       Impact factor: 2.778

Review 2.  Hypertrophic cardiomyopathy.

Authors:  B J Maron
Journal:  Lancet       Date:  1997-07-12       Impact factor: 79.321

3.  Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial.

Authors:  R A Nishimura; J M Trusty; D L Hayes; D M Ilstrup; D R Larson; S N Hayes; T G Allison; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1997-02       Impact factor: 24.094

4.  Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points.

Authors:  S R Ommen; R A Nishimura; R W Squires; H V Schaff; G K Danielson; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

5.  Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group.

Authors:  L Kappenberger; C Linde; C Daubert; W McKenna; E Meisel; N Sadoul; L Chojnowska; L Guize; D Gras; X Jeanrenaud; L Rydén
Journal:  Eur Heart J       Date:  1997-08       Impact factor: 29.983

6.  Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy.

Authors:  K McDonald; E McWilliams; B O'Keeffe; B Maurer
Journal:  Eur Heart J       Date:  1988-08       Impact factor: 29.983

7.  Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.

Authors:  L Fananapazir; N D Epstein; R V Curiel; J A Panza; D Tripodi; D McAreavey
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

8.  DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience.

Authors:  A K Slade; N Sadoul; L Shapiro; L Chojnowska; J P Simon; R C Saumarez; B Dodinot; A J Camm; W J McKenna; E Aliot
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

9.  Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy.

Authors:  X Jeanrenaud; J J Goy; L Kappenberger
Journal:  Lancet       Date:  1992-05-30       Impact factor: 79.321

Review 10.  The management of hypertrophic cardiomyopathy.

Authors:  P Spirito; C E Seidman; W J McKenna; B J Maron
Journal:  N Engl J Med       Date:  1997-03-13       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.